- Practice your UTHR trading strategies and win cash in our stock game.
NEW YORK ( TheStreet) -- United Therapeutics Corporation (Nasdaq: UTHR) hit a new 52-week low Tuesday as it is currently trading at $36.75, below its previous 52-week low of $36.80 with one million shares traded as of 3:06 p.m. ET. Average volume has been 1.5 million shares over the past 30 days. United has a market cap of $2.2 billion and is part of the health care sector and drugs industry. Shares are down 41.1% year to date as of the close of trading on Monday. United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and Internationally. The company has a P/E ratio of 16.2, below the average drugs industry P/E ratio of 16.6 and below the S&P 500 P/E ratio of 17.7.